RedMabs certified by AENOR

2022 Jul 12
On 2022. 07. 11 AENOR has granted BioClonal the project certificate for RedMabs, an innovative platform to  generate Real Biobetters from any therapeutic mab given, according to Program of R + D + i projects, in the field of the manufacturing industry (EDGE HEALTH PERTE), according to Order ICT/309/2022.
Image for RedMabs certified by AENOR
financiado por la Unión Europea - NextGenerationEU